MVP
AGN

Miller Value Partners’s Allergan plc AGN Stock Holding History

Miller Value Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-278,655
Closed -$40.8M – 115
2019
Q1 		$40.8M Sell
278,655
-320
-0.1% -$46.4K 1.62% 27
2018
Q4 		$37.3M Sell
278,975
-280
-0.1% -$45.9K 1.69% 27
2018
Q3 		$53.2M Buy
279,255
+7,765
+3% +$1.43M 1.72% 29
2018
Q2 		$45.3M Sell
271,490
-320
-0.1% -$51.4K 1.69% 30
2018
Q1 		$45.7M Buy
271,810
+112,685
+71% +$18.9M 1.91% 23
2017
Q4 		$26M Sell
159,125
-2,350
-1% -$422K 1.11% 30
2017
Q3 		$33.1M Sell
161,475
-3,650
-2% -$849K 1.42% 27
2017
Q2 		$40.1M Sell
165,125
-5,600
-3% -$1.32M 1.63% 24
2017
Q1 		$40.8M Buy
170,725
+37,710
+28% +$8.78M 1.79% 24
2016
Q4 		$27.9M Buy
+133,015
New +$27.6M 1.23% 29

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Miller Value Partners's AGN Position: Q2 2019 in Review

Miller Value Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 278,655 shares — an estimated $40.8M sold.

Miller Value Partners first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $53.2M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Miller Value Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Miller Value Partners sold 278,655 Allergan plc shares in Q2 2019, an estimated $40.8M.
  • Miller Value Partners first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • Miller Value Partners's Allergan plc position peaked at $53.2M in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Miller Value Partners's 13F filing for Q2 2019, filed 14 Aug 2019.